ASTC Nasdaq Laboratory Analytical Instruments Financials FY2017βFY2026
ASTROTECH Corp had $0.9M of revenue in fiscal 2026, down 8.7% on the year before. Over five years, revenue changed +22.3% a year on average.
Last close Β· Oct 23, 2026
$5.04
0.4%Hi! I read ASTROTECH Corpβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
β8.7%
No. Sales fell 8.7% last year.
Does it make a profit?
β1,580.2%
No. It lost money last year.
Does profit turn into cash?
β1,569.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 7
Weak. It passes 2 of 7 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· ASTROTECH Corp had $0.9M of revenue in fiscal 2026, down 8.7% on the year before. Over five years, revenue changed +22.3% a year on average. Its operating margin was β1,548.5%, down 75.1Β pts: of every 100 in sales, about β1,549 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· ASTROTECH Corp lost $14.4M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$14.3M in fiscal 2026, β1,569.8% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 3, 2025 | Braden Michael Leonard10% owner | Sold | 229,576 | $7.08 | $1.6M | Form 4 |
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably ASTROTECH Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | β | β | β | $18.2M | $11.3M |
| Current ratio | 20.5x | 16.8x | 13.7x | 9.0x | 7.1x |
| Quick ratio | 20.5x | 16.8x | 13.7x | 9.0x | 7.1x |
| Total assets | $56.2M | $47.7M | $37.6M | $27.0M | $20.5M |
| Total liabilities | $3.0M | $3.0M | $2.8M | $4.9M | $4.3M |
| Shareholders' equity | $53.2M | $44.7M | $34.8M | $22.1M | $16.2M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· ASTROTECH Corp passes 2 of 7 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 2 / 8 | 3 / 8 | 4 / 8 | 4 / 7 | 3 / 7 | 3 / 7 | 2 / 7 | 2 / 7 |
| Accruals ratio | β14.7% | β20.6% | 21.3% | β28.7% | β0.6% | β2.5% | β3.9% | β4.6% | β2.8% | β4.1% |
| Altman Z'' | β21.23 | β126.36 | β178.35 | β118.54 | 9.50 | 11.29 | 4.70 | β4.39 | β24.48 | β38.52 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.3M | $0.1M | $0.1M | $0.5M | $0.3M | $0.9M | $0.8M | $1.7M | $1.0M | $0.9M |
| Gross profit | $1.0M | $0.1M | $0.0M | $0.0M | $0.0M | $0.2M | $0.3M | $0.8M | $0.5M | $0.2M |
| Research and development | $5.6M | $6.1M | $3.6M | $3.4M | $2.7M | $2.8M | $5.6M | $6.8M | $8.1M | $6.5M |
| Operating income | β$12.1M | β$13.3M | β$8.4M | β$8.1M | β$7.9M | β$8.6M | β$11.1M | β$13.3M | β$14.7M | β$14.1M |
| Pretax income | β$11.8M | β$13.3M | β$8.4M | β$8.3M | β$7.6M | β$8.3M | β$9.6M | β$11.7M | β$13.8M | β$14.4M |
| Income tax | $0.0M | $0.0M | β$0.9M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$11.6M | β$13.3M | β$7.5M | β$8.3M | β$7.6M | β$8.3M | β$9.6M | β$11.7M | β$13.9M | β$14.4M |
| Diluted EPS | β$2.84 | β$3.26 | β$1.53 | β$1.31 | β$0.35 | β | β | β | β | β |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.01B | 0.02B | β | β | β | β | β |
| Cash flow | ||||||||||
| Cash from operations | β$8.8M | β$10.8M | β$8.5M | β$6.9M | β$7.4M | β$6.8M | β$7.6M | β$9.7M | β$13.0M | β$13.5M |
| Capital expenditure | $0.5M | $0.0M | $0.0M | $0.0M | $0.2M | $0.6M | $1.8M | $0.6M | $0.8M | $0.9M |
| Free cash flow | β$9.3M | β$10.8M | β$8.5M | β$6.9M | β$7.6M | β$7.4M | β$9.5M | β$10.3M | β$13.8M | β$14.3M |
| Depreciation and amortization | $0.7M | $0.7M | $0.3M | $0.5M | $0.2M | $0.2M | $0.4M | $0.7M | $1.0M | $0.9M |
| Stock-based compensation | $1.1M | $0.5M | $0.3M | $0.3M | $0.6M | $1.5M | $1.5M | $1.5M | $0.8M | $0.9M |
| Share buybacks | β | β | β | β | β | $0.0M | $0.1M | $0.0M | β | β |
| Dividends and buybacks | β | β | β | β | β | $0.0M | $0.1M | $0.0M | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $13.1M | $4.1M | $1.6M | $3.3M | $63.3M | β | β | β | $18.2M | $11.3M |
| Total debt | $0.0M | $0.0M | β | β | β | β | β | β | β | β |
| Finance lease liabilities | β | β | β | $0.0M | $0.0M | β | β | $0.2M | $0.1M | $0.0M |
| Current assets | $13.7M | $4.3M | $2.7M | $4.7M | $65.1M | $55.0M | $44.7M | $34.7M | $22.0M | $15.9M |
| Current liabilities | $1.8M | $1.0M | $0.8M | $4.4M | $4.2M | $2.7M | $2.7M | $2.5M | $2.5M | $2.3M |
| Inventory | $0.2M | $0.0M | β | β | β | β | β | β | β | β |
| Property and equipment, net | $3.2M | $0.7M | $0.5M | $0.1M | $0.3M | $1.1M | $2.7M | $2.8M | $2.4M | $2.4M |
| Intangible assets | β | β | β | β | β | β | β | $0.0M | $0.0M | $0.1M |
| Total assets | $18.8M | $5.1M | $3.7M | $5.9M | $65.6M | $56.2M | $47.7M | $37.6M | $27.0M | $20.5M |
| Total liabilities | $2.1M | $1.1M | $1.0M | $5.3M | $4.4M | $3.0M | $3.0M | $2.8M | $4.9M | $4.3M |
| Preferred stock | $0.0M | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $16.8M | $4.0M | $2.7M | $0.6M | $61.2M | $53.2M | $44.7M | $34.8M | $22.1M | $16.2M |
| Margins | ||||||||||
| Gross margin | 44.5% | 58.1% | 29.1% | 8.0% | 10.8% | 22.1% | 40.8% | 44.2% | 47.5% | 23.8% |
| Operating margin | β518.0% | β15,508.1% | β6,627.6% | β1,662.7% | β2,368.3% | β989.1% | β1,474.7% | β781.2% | β1,473.4% | β1,548.5% |
| EBITDA margin | β487.5% | β14,637.2% | β6,416.5% | β1,553.5% | β2,307.5% | β961.9% | β1,425.9% | β738.2% | β1,377.2% | β1,450.4% |
| Net margin | β497.5% | β15,408.1% | β5,932.3% | β1,703.1% | β2,276.3% | β958.6% | β1,285.6% | β686.2% | β1,385.0% | β1,580.2% |
| FCF margin | β400.3% | β12,561.6% | β6,673.2% | β1,420.3% | β2,278.1% | β850.2% | β1,262.5% | β606.1% | β1,378.5% | β1,569.8% |
| Returns | ||||||||||
| Return on capital | β258.5% | β | β | β | β | β | β | β | β | β |
| Return on capital employed | β70.8% | β319.1% | β294.9% | β513.5% | β12.9% | β16.1% | β24.6% | β37.8% | β60.0% | β77.5% |
| Return on equity | β69.1% | β127.6% | β224.9% | β498.7% | β24.6% | β14.6% | β19.7% | β29.3% | β48.7% | β75.4% |
| Return on assets | β61.5% | β110.5% | β170.6% | β172.7% | β21.2% | β13.7% | β18.6% | β27.3% | β42.9% | β60.8% |
| Return on tangible equity | β69.1% | β331.9% | β278.2% | β1,329.8% | β12.4% | β15.6% | β21.6% | β33.5% | β62.8% | β89.5% |
| Growth | ||||||||||
| Revenue growth | β | β96.3% | 47.7% | 284.3% | β31.6% | 160.2% | β13.7% | 126.7% | β41.2% | β8.7% |
| Share count change | β | β0.6% | 21.6% | 28.5% | 246.4% | β | β | β | β | β |
| Financial health | ||||||||||
| Debt / equity | 0.0x | 0.0x | β | β | β | β | β | β | β | β |
| Current ratio | 7.6x | 4.5x | 3.2x | 1.1x | 15.5x | 20.5x | 16.8x | 13.7x | 9.0x | 7.1x |
| Quick ratio | 7.5x | 4.4x | 3.2x | 1.1x | 15.5x | 20.5x | 16.8x | 13.7x | 9.0x | 7.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 21.4% | 22.1% | 0.0% | 0.0% | 63.2% | 68.6% | 245.9% | 34.1% | 83.3% | 96.3% |
| Stock comp / revenue | 48.7% | 523.3% | 240.2% | 71.3% | 187.4% | 176.6% | 199.7% | 86.9% | 83.0% | 100.9% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 2.0 | 3.0 | 4.0 | 4.0 | 3.0 | 3.0 | 2.0 | 2.0 |
| Altman Z'' | β21.2 | β126.4 | β178.4 | β118.5 | 9.5 | 11.3 | 4.7 | β4.4 | β24.5 | β38.5 |
| Accruals ratio | β14.7% | β20.6% | 21.3% | β28.7% | β0.6% | β2.5% | β3.9% | β4.6% | β2.8% | β4.1% |
Source: SEC EDGAR XBRL filings (CIK 0001001907). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
